Literature DB >> 25350982

Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure.

Faiez Zannad1, Wendy Gattis Stough2, Felix Mahfoud2, George L Bakris2, Sverre E Kjeldsen2, Robert S Kieval2, Hermann Haller2, Nadim Yared2, Gaetano M De Ferrari2, Ileana L Piña2, Kenneth Stein2, Michel Azizi2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25350982     DOI： 10.1161/HYPERTENSIONAHA.114.04057

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

Review 1.  Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.

Authors:  Kristine Chobanyan-Jürgens; Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

2.  Early activation of ubiquitin-proteasome system at the diaphragm tissue occurs independently of left ventricular dysfunction in SHR rats.

Authors:  Pamella Ramona Moraes de Souza; Renata Kelly da Palma; Rodolfo Paula Vieira; Fernando Dos Santos; Wilson Max Almeida Monteiro-De-Moraes; Alessandra Medeiros; Marcia Kiyomi Koike; Fernanda Magalhães Arantes-Costa; Kátia De Angelis; Maria Claudia Irigoyen; Fernanda Marciano Consolim Colombo
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-27

3.  Electrical stimulation of the carotid sinus lowers arterial pressure and improves heart rate variability in L-NAME hypertensive conscious rats.

Authors:  Gean Domingos-Souza; Fernanda Machado Santos-Almeida; César Arruda Meschiari; Nathanne S Ferreira; Camila A Pereira; Diana Martinez; Daniel Penteado Martins Dias; Luiz Eduardo Virgílio Silva; Jaci Airton Castania; Rita C Tostes; Rubens Fazan
Journal:  Hypertens Res       Date:  2020-05-01       Impact factor: 3.872

Review 4.  Interventional procedures and future drug therapy for hypertension.

Authors:  Melvin D Lobo; Paul A Sobotka; Atul Pathak
Journal:  Eur Heart J       Date:  2017-04-14       Impact factor: 29.983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.